Infection Clinical Trial
Official title:
Bacterial Contamination of Operative Splash Basins: Can it be Prevented?
The primary objective of this study is to compare the efficacy of adding 0.05% chlorhexidine
gluconate to the splash basin in reducing bacterial growth from splash basins at the end of
a total joint replacement procedure.
Hypothesis: The 0.05% chlorhexidine gluconate solution will reduce the bacterial growth at
the end of elective total joint arthroplasty cases.
Null Hypothesis: There will be no difference in bacterial growth from the splash basin at
the end of the case despite the addition of an antimicrobial solution.
Total joint arthroplasty of the hip and knee is a procedure growing substantially in number
in the United States. Projections approach 2 million combined total hip and total knee
arthroplasty procedures by the year 2021[1, 2]. With the incidence of post-arthroplasty
infection ranging from 1-2% of primaries and 3-5% of revisions, the number of cases of
periprosthetic infection will be significant[1, 3-7]. The associated economic burden is
projected to exceed $1.62 billion[2]. With these numbers in mind it is our responsibility in
the orthopaedic community to do what we can to reduce the social and economic impact that
this devastating complication creates.
While all surgical procedures carry the risk of bacterial contamination, those that implant
prosthetic material are particularly high risk for future problems due to the development of
biofilms and difficulty eradicating such infections. The most common time of inoculation of
the implant is at the time of surgery. Whyte et al.[8] showed that the source of infection
was the operating room personnel in 98% of cases while only 2% of the time it was the
patient's own skin. The transfer of contaminants occurred via direct transfer through the
hands or instruments 70% of the time. Knobben et al.[9] reported transfer of bacteria
between biomaterial surfaces at a rate of 17%-71% demonstrating the ability of bacteria to
spread to all types of materials in the operative field. The direct contact of these
surfaces with the patient or prosthetic implant makes early contamination during surgery a
likely cause of periprosthetic infection. Maathuis et al.[10] suggested that at least 30% of
patients leave the operating suite with bacterial contamination.
The splash basin has been used for many years in the operating room as a place to wash
instruments and clean them of debris for potential re-use during the surgical case. This
often places multiple instruments within the bath of washings or in direct contact with
previously used tools. Several studies have shown evidence of bacterial contamination of
these basins[11-14]. Rates of 2.17% to 74% of contamination of the splash basin have been
reported. In a study by Anto et al.[11] an average of 45.7 instruments were placed in the
splash basin per case. The opportunity for bacteria to be transferred to the surgical wound
upon re-use of an instrument from the basin is therefore concerning.
Given that the splash basin is a potential source of surgical wound contamination we have
sought to eliminate the bacterial colonization of this source through the addition of an
antimicrobial solution to the normal sterile water bath. To compare potential interventions,
a prospective study comparing a 0.05% chlorhexidine gluconate (CHG) antimicrobial solution
to the current standard of sterile water as a control is proposed. This concentration of CHG
followed by a saline rinse has been shown to decrease the risk of infection during wound
irrigation without increasing the risk of adverse effects[15, 16].
Given our expertise in the area of total joint arthroplasty and experience with treating
periprosthetic infections as well as familiarity with various antimicrobial solutions we
feel well qualified to perform this study. The results of this study could improve patient
outcomes by potentially eliminating a source of infection in the operating room.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04529421 -
Assocation Between In-person Instruction and COVID-19 Risk
|
||
| Recruiting |
NCT04081792 -
Optimal Antibiotics for Operated Diabetic Foot Infections
|
N/A | |
| Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
| Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
| Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
| Recruiting |
NCT00342589 -
New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia
|
||
| Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
| Completed |
NCT03296423 -
Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly
|
Phase 4 | |
| Withdrawn |
NCT04217252 -
Clinical Application of High-throughput Sequencing Technology for the Diagnosis of Patients With Severe Infection
|
N/A | |
| Recruiting |
NCT02905552 -
Myelodysplasic Syndromes and Risk Factors for Infection
|
N/A | |
| Recruiting |
NCT02899143 -
Short-course Antimicrobial Therapy in Sepsis
|
Phase 2 | |
| Withdrawn |
NCT02904434 -
Gastrointestinal Implications of Voriconazole Exposure
|
||
| Active, not recruiting |
NCT02768454 -
Antimicrobials Stewardship by Pharmacist
|
N/A | |
| Completed |
NCT02219776 -
Decreasing Infection In Arthroscopic Shoulder Surgery
|
N/A | |
| Completed |
NCT02210169 -
RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates
|
N/A | |
| Recruiting |
NCT02098226 -
Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts
|
N/A | |
| Completed |
NCT01846832 -
A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection
|
Phase 3 | |
| Terminated |
NCT01441206 -
Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
|
Phase 1 | |
| Completed |
NCT01434797 -
Value of PET/CT Imaging in the Diagnosis of Permanent Central Venous Catheters Infection
|
||
| Completed |
NCT01159834 -
Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
|
N/A |